| Market Capitalization (Millions $) |
4,896 |
| Shares
Outstanding (Millions) |
132 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-26 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Marizyme is a life sciences company that specializes in developing and commercializing innovative therapies and products that utilize enzymes. The company is dedicated to improving human and animal health by harnessing the power of enzymes to create safe, effective, and affordable therapies.
The company was founded in 2017 by biological engineers with deep experience in the development of cutting-edge enzyme technologies. Marizyme's team has a strong background in the discovery, optimization, and commercialization of enzymes, as well as in the development of novel applications for enzymes in healthcare, agriculture, and beyond.
Marizyme's lead product candidate is DuraGraft, a proprietary solution that improves the outcomes of vascular surgeries. DuraGraft is an enzymatic solution that is designed to improve the functionality and quality of vascular grafts used in bypass surgeries. The company has completed clinical trials of DuraGraft, which demonstrated statistically significant improvements in graft outcomes.
In addition to DuraGraft, Marizyme has a pipeline of other product candidates in development, including enzyme therapies for conditions such as cystic fibrosis, cancer, and spinal cord injury. The company is also exploring potential applications of enzymes in areas such as food and agriculture.
To support its research and development efforts, Marizyme has established partnerships with leading academic institutions and research organizations. The company has also secured funding from a variety of sources, including private investors, government grants, and strategic partnerships.
Overall, Marizyme is a pioneering life sciences company that is working to bring the power of enzymes to the forefront of modern medicine. The company's innovative approach has the potential to transform the treatment of a wide range of conditions and improve the lives of millions of people around the world.
Company Address: 555 Heritage Drive Jupiter 33458 FL
Company Phone Number: 935-9955 Stock Exchange / Ticker: MARZ
|
14.1% 